CTNNB1 and hepatocellular carcinoma: Consistent with TCGA, CTNNB1 is one of the top mutated genes in the Taiwanese HCC cohort and has a male-biased tendency [24], which predicts that males will receive greater therapeutic benefit from Wnt or β-catenin-targeting regimens.